Predicting the likelihood and intensity of mosquito infection from sex specific Plasmodium falciparum gametocyte density

  1. John Bradley
  2. Will Stone
  3. Dari F Da
  4. Isabelle Morlais
  5. Alassane Dicko
  6. Anna Cohuet
  7. Wamdaogo M Guelbeogo
  8. Almahamoudou Mahamar
  9. Sandrine Nsango
  10. Harouna M Soumaré
  11. Halimatou Diawara
  12. Kjerstin Lanke
  13. Wouter Graumans
  14. Rianne Siebelink-Stoter
  15. Marga van de Vegte-Bolmer
  16. Ingrid Chen
  17. Alfred Tiono
  18. Bronner Pamplona Gonçalves
  19. Roland Gosling
  20. Robert W Sauerwein
  21. Chris Drakeley
  22. Thomas S Churcher  Is a corresponding author
  23. Teun Bousema
  1. London School of Hygiene and Tropical Medicine, United Kingdom
  2. Radboud University Medical Center, Netherlands
  3. Institut de Recherche en Sciences de la Santé, Direction, Burkina Faso
  4. MIVEGEC (UM-CNRS 5290-IRD 224), France
  5. University of Science, Techniques and Technologies of Bamako, Mali
  6. Université de Douala, Cameroon
  7. University of California, San Francisco, United States
  8. Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso
  9. Imperial College London, United Kingdom

Abstract

Understanding the importance of gametocyte density on human-to-mosquito transmission is of immediate relevance to malaria control. Previous work (Churcher et al., 2013) indicated a complex relationship between gametocyte density and mosquito infection. Here we use data from 148 feeding experiments on naturally infected gametocyte carriers to show that the relationship is much simpler and depends on both female and male parasite density. The proportion of mosquitoes infected is primarily determined by the density of female gametocytes though transmission from low gametocyte densities may be impeded by a lack of male parasites. Improved precision of gametocyte quantification simplifies the shape of the relationship with infection increasing rapidly before plateauing at higher densities. The mean number of oocysts per mosquito rises quickly with gametocyte density but continues to increase across densities examined. The work highlights the importance of measuring both female and male gametocyte density when estimating the human reservoir of infection.

https://doi.org/10.7554/eLife.34463.001

Introduction

Mosquitoes must ingest both male and female mature gametocytes to become infected with malaria. The shape of the relationship between gametocyte density and the probability of mosquito infection is thought to be complex for Plasmodium falciparum (Churcher et al., 2013; Lin et al., 2016; Da et al., 2015); but recent evidence has shown that the most comprehensive characterisation of this relationship was conducted using molecular tools that only quantified female gametocyte specific Pfs25 mRNA (Churcher et al., 2013; Lasonder et al., 2016). An additional shortcoming of these previous estimates is that female gametocytes were quantified from trendlines with unknown gametocyte sex-ratios, potentially affecting assay precision.

It is intuitive that gametocyte sex ratio is important in determining transmission efficiency (Reece et al., 2008; Paul et al., 2002). Gametocyte sex-ratio in P. falciparum is typically female biased but may differ between infections (West et al., 2001; Robert et al., 2003) and during infections (West et al., 2001; Paul et al., 2000), and may be influenced by immune responses that differentially affect male and female gametocytes (Ramiro et al., 2011). Fertility assurance explains why under certain conditions, such as a low gametocyte density, gametocyte sex-ratio may become less female biased to ensure all female gametes are fertilised (Gardner et al., 2003). Despite evidence that gametocyte sex ratio is adjusted in response to malaria developmental bottlenecks (Reece et al., 2008; Paul et al., 2002; Neal and Taylor, 2014), there is no direct evidence for its epidemiological importance. Since mosquito infections may occur from blood with P. falciparum gametocyte densities below the microscopic threshold for detection (Churcher et al., 2013; Gonçalves et al., 2017) and gametocyte density itself is an important determinant of sex ratio (Reece et al., 2008; Robert et al., 2003), sensitive quantification of male and female gametocytes is essential for assessments of the role of gametocyte sex ratio in natural infections and for reliable estimates of total gametocyte density. Here, we use a new molecular target of male P. falciparum gametocytes (Pf3D7_1469900 or PfMGET) (Stone et al., 2017) to explore the association between the density of female and male gametocytes and mosquito infection prevalence. The relationship between gametocyte density and oocyst density is also investigated as this may show a different relationship with gametocyte density (Da et al., 2015) and recent work has highlighted the potential importance of mosquito parasite density in mosquito-to-human transmission (Churcher et al., 2017). Both the number of infected mosquitoes and their parasite load may thus need to be considered when assessing the human reservoir of infection.

Results

Participant characteristics

Gametocyte carriers were included from Mali (n = 71), Burkina Faso (n = 64) and Cameroon (n = 13). P. falciparum parasite prevalence by microscopy ranged from ~40–70% between sites (Gonçalves et al., 2017; Hien et al., 2017; Mahamar et al., 2017; Sandeu et al., 2017); sampling occurred in different seasons (Table 1). All sites recruited gametocyte carriers prior to antimalarial treatment but used different enrolment criteria. Microscopically detected gametocyte carriers were included in three studies while one site (Balonghin) included submicroscopic gametocyte densities. Total gametocyte densities ranged from 0.04 to 1164 gametocytes/μL; the median proportion of male gametocytes was 25% (interquartile range 13–39%)(Table 1, Figure 1). Gametocyte density estimates by microscopy and qRT-PCR were positively correlated in all sites, but there was variation in the strength of correlation: Ouelessebougou (r = 0.74), Bobo Dioulasso (r = 0.27), Balonghin (r = 0.56) and Yaoundé (r = 0.91) (Figure 1—figure supplement 1). Across 148 successful membrane feeding experiments, 16.7% (1297/7757) of mosquitoes became infected, with considerable variation between gametocyte donors and study sites.

Figure 1 with 1 supplement see all
Gametocyte density in natural infections.

The density of female gametocytes and male gametocytes is presented in panel (A) for samples from Ouelessebougou, Mali (red), Yaoundé, Cameroon (green), Bobo-Dioulasso, Burkina Faso (blue) and Balonghin, Burkina Faso (purple). Female and male gametocyte densities were positively associated (r = 0.79, p<0.001) with the best fit relationship shown by the black solid line (grey shaded area showing 95% the confidence interval around this line). Coloured horizontal and vertical lines indicate Bayesian credible intervals (CIs) around point estimates. The proportion of gametocytes that were male was negatively associated with total gametocyte density (B) but not with asexual parasite density (C). All raw data can be found in Figure 1—source data 1 whilst a description of the relationship modelled in (A) is provided in Figure 1—source data 2. The relationship between gametocyte density as measured by microscopy and PCR is given for each site in Figure 1—figure supplement 1.

https://doi.org/10.7554/eLife.34463.002
Figure 1—source data 1

Raw data presented in Figure 1.

https://doi.org/10.7554/eLife.34463.004
Figure 1—source data 2

Description of the statistical model determining the shape of the relationship between female gametocyte density and male gametocyte density.

https://doi.org/10.7554/eLife.34463.005
Table 1
Characteristics of gametocyte carriers and mosquito feeding assays.
https://doi.org/10.7554/eLife.34463.006
Ouelessebougou, MaliBobo Dioulasso,
Burkina Faso
Balonghin,
Burkina Faso
Yaoundé,
Cameroon
Number of experiments71194513
Enrolment criteria:Detection of gametocytes by microscopyDetection of gametocytes by microscopyDetection of gametocytes by molecular QT-NASBADetection of gametocytes by microscopy
Period and season of data collectionJanuary 2013-November 2014 (dry and wet season)April-June 2016 (dry season)October-November 2014 (wet season)October-December 2015 (wet season)
P. falciparum parasite prevalence in cross-sectional surveys in the study area (microscopy)70.2% in children < 5 years, 2015–16 (Mahamar et al., 2017)40.9–61.7% in children 1–9 years, 2014–2015 (Hien et al., 2017)59.7% in children < 15 years, 2014 wet season (Gonçalves et al., 2017)44.7–55.6% in children 4–15 years, 2013–2014 (Sandeu et al., 2017)
Age, median (IRQ)11 (7–25)5–15 (range)*10 (8–13)9 (6–11)
Asexual parasite prevalence % (n/N)64.8 (46/71)73.7 (14/19)73.3 (33/45)76.9 (10/13)
Asexual parasite density per µL, median (IQR)432 (96–2880)360 (240–1040)658 (336–1237)944 (288–4224)
Total gametocyte density per µL, median (IQR)62.8 (31.4–146.8)19.2 (10.5–26.1)4.0 (0.6–11.0)64.4 (11.7–126.2)
Percentage of male gametocytes, median (IQR)14% (7–25%)51% (39–66%)30% (18–40%)32% (27–53%)
Number of mosquitoes examined per experiment, median (IQR)70 (63–79)29 (28–30)40 (35–45)37 (32–45)
Infectious individuals, % (n/N)74.7 (53/71)84.2 (16/19)22.2 (10/45)76.9 (10/13)
Infected mosquitoes, % (n/N)17.0 (842/4960)39.2 (208/531)3.5 (63/1783)38.1 (184/483)
  1. *the age of individual gametocyte donors was not recorded in Bobo Dioulasso; gametocyte carriers were recruited from the age range 5–15 years; asexual parasite density was determined by microscopy, gametocyte density by quantitative reverse transcriptase PCR. QT-NASBA = Pfs25 mRNA quantitative nucleic acid sequence based amplification.

Gametocyte sex ratios in natural infections

Female gametocyte densities quantified by Pfs25 quantitative reverse-transcriptase PCR (qRT-PCR) and male gametocyte densities by PfMGET qRT-PCR were positively correlated (Figure 1A; Spearman’s rank correlation coefficient = 0.79, p<0.001). The fact that the relationship is linear on the log scale means that the percentage of gametocytes that were male decreased with increasing total gametocyte densities (Figure 1B, p<0.001 [Kruskal Wallis test]). This association remained apparent and statistically significant if any of the study sites with a smaller number of observations was removed (i.e. with removal of data from Bobo Dioulasso, Balonghin or Yaoundé). Conversely there was no evidence for an association between proportion of male gametocytes with asexual parasite density (Figure 1C, p=0.713).

Infectivity in relation to gametocyte density

The proportion of mosquitoes developing oocysts is best described by a model that incorporates both the density of female and the density of male gametocytes (deviance information criterion, DIC = 451.5). In the best fit model, female gametocyte density explains most of the variability with the proportion of mosquitoes infected increasing rapidly with increasing gametocytaemia before saturating at high female gametocyte densities (Figure 2A). At female gametocyte densities of 200 per µl approximately 30% of mosquitoes are infected. At low gametocyte densities transmission appears to be impeded by a lack of male parasites (Figure 2B). The number of mosquitoes infected is on average lower for hosts with fewer than 50 male gametocytes per µl of blood, with the model predicting that male densities < 10 per µl reduces the proportion of infected mosquitoes by 50% (Figure 2C). Predictions for the proportion of mosquitoes infected according to the density of female and male gametocytes in the blood is given in Figure 2D. Poorer statistical fits were observed for models where the proportion of mosquitoes with oocysts was described by either the density of females alone (DIC = 481.3), the density of males (DIC = 538.8), or total gametocyte density (sum of male and female gametocytes, DIC = 501.7). There were considerable differences in the relative infectivity between sites. Compared to the Mali data, infectivity was similar in the study in Balonghin, Burkina Faso (0.95 times as high; 95% CI 0.1–1.4) but 3.65 times higher in Bobo Dioulasso, Burkina Faso (95% CI 2.3–5.2) and 1.68 times higher in site in Yaoundé, Cameroon (95% CI 1.1–2.6) (Figure 2—figure supplement 1, Figure 2—source data 2.). Other models, including both qRT-PCR and microscopy, showed poorer performance in predicting mosquito infection prevalence (Figure 2—source data 2).

Figure 2 with 2 supplements see all
The relationship between Plasmodium falciparum gametocyte density and the proportion of mosquitoes that develop oocysts.

(A) The association with female gametocyte density. The solid black line indicates the best-fit statistical model with grey shaded 95% Bayesian credible intervals (CI). Infectivity depends on both the density of male and female gametocytes so the figure uses the relationship between male and female gametocyte density defined in Figure 1A to predict overall transmission. Point colour denotes the study from which the observation came (red = Ouelessebougou, Mali, green = Yaoundé, Cameroon, blue = Bobo Dioulasso, Burkina Faso and purple = Balonghin, Burkina Faso) and point size is proportional to the number of mosquitoes dissected. Horizontal and vertical lines indicate 95% CIs around point estimates. To aid clarity the figure shows points and model predictions scaled to the largest dataset (i.e. each site was scaled by the relative infectivity compared to the Mali dataset). A version of the figure without this scaling is shown in Figure 2—figure supplement 1, which shows all raw data and separate model predictions for each site. (B) Relationship between female gametocyte density and the proportion of infected mosquitoes for different male gametocyte densities for experiments from Mali (n = 71). Points are coloured according to the density of male gametocytes (<10 male gametocytes/µL = pink,≥10 male gametocytes/µL = dark blue). Note bloodmeals containing lower numbers of male parasites typically have lower infectivity for a given female density. Figure 2—figure supplement 2 shows the same figure but differentiating between points using the sex ratio instead of absolute male density. (C) Model predictions for the reduction in the proportion of mosquitoes infected due to male gametocyte density. Data points are the observed infectivity divided by the predicted infectivity as predicted by the statistical model using the density of female gametocytes in the sample (colours matching panel A). Values less than one indicate reductions in relative transmission. The solid black line shows the best fit model for this restriction from the model in 2A, with shaded area and horizontal and vertical lines indicating 95% CIs. (D) illustrates the best fit model predictions for the 3D relationship between female gametocyte density, male gametocyte density and the percentage of mosquitoes which develop oocysts (colour scale from 0 to ≥50% infected mosquitoes, see legend). All raw data can be found in Figure 2—source data 1 whilst statistical comparisons of the different curves tested in (A) are provided in Figure 2—source data 2.

https://doi.org/10.7554/eLife.34463.007
Figure 2—source data 1

Raw data presented in Figure 2.

https://doi.org/10.7554/eLife.34463.010
Figure 2—source data 2

Description of the statistical model determining the shape of the relationship between gametocyte density and mosquito infection.

https://doi.org/10.7554/eLife.34463.011

Oocyst density in mosquitoes

The distribution of oocysts between mosquitoes is highly over-dispersed, with some mosquitoes harbouring very high oocyst densities. This aggregated distribution is reflected in the relationship between proportion of mosquitoes infected and mean oocyst density (Figure 3A). Mean oocyst density increased with increasing gametocyte density and continued to increase across the range of gametocyte densities observed, without evidence for a plateau being reached (Figure 3B). Total gametocyte density (sum of females and males) was able to predict mean oocyst density better than female gametocyte density alone. The higher complexity of the density model (requiring the fitting of the negative binomial distribution) meant that it was not possible to fit a model analogous to the best fit model on infectivity (i.e. a function dependent on female gametocyte density but with reduced transmission at low male densities). Care should be taken interpreting the relative importance of females and male gametocytes in predicting oocyst density as this result should be validated with a larger dataset.

Figure 3 with 1 supplement see all
Associations between mean oocyst density; the proportion of mosquitoes that develop oocysts; and gametocyte density.

(A) The relationship between mean oocyst density and the proportion of mosquitoes that develop oocysts (red = Ouelessebougou, Mali, green = Yaoundé, Cameroon, blue = Bobo Dioulasso, Burkina Faso, purple = Balonghin, Burkina Faso; point size is proportional to the number of mosquitoes dissected). A Hill function gave the best fit to these data (DIC linear = 1310; power = 602; Hill = 434). (B) The relationship between total gametocyte density and the mean oocyst density in all mosquitoes. The power function gave the best fit to these data (DIC linear = 1042; hyperbolic = 1044; gompertz = 1067; power = 1036); total gametocyte density gave a better fit than only female gametocyte density (best DIC = 1061). Horizontal and vertical lines indicate 95% Bayesian credible intervals (CIs) around point estimates, solid black line indicates the best-fit model with grey shaded area indicates the 95% CI around this line. Like Figure 2A, Panel 3B aids clarity by scaling model and data to the average infectivity of the largest dataset though the raw data and model fits are provided in Figure 3—figure supplement 1.

https://doi.org/10.7554/eLife.34463.012

Discussion

We present an improved model to predict mosquito infection from female and male gametocyte density estimates. Previous molecular assessments of P. falciparum gametocyte density quantified female specific Pfs25 mRNA then converted this into a measure of gametocytes per µL of blood by reference to standard curve of mixed-sex gametocytes (Churcher et al., 2013; Wampfler et al., 2013; Ouédraogo et al., 2016). These assessments therefore quantified neither female nor total gametocyte density accurately. The current model presents a considerable improvement over previous work (Churcher et al., 2013), both by separately quantifying male and female gametocytes using sex-specific mRNA markers and standard curves (Lasonder et al., 2016) and also by using considerably more accurate estimates of total gametocyte density. Male and female gametocytes were quantified separately using automated extraction of nucleic acids (Stone et al., 2017). Manual extraction can result in considerable variation (Walker et al., 2015) that may have affected the accuracy of our earlier gametocyte estimates (Churcher et al., 2013). In addition, we used qRT-PCR that has higher precision than the previously used quantitative nucleic acid sequence based amplification, QT-NASBA (Pett et al., 2016).

The analyses show that the relationship between the density of gametocytes and transmission can be adequately described by a simple saturating relationship, and that a more complicated curve with two inflection points (which generates a double plateau) does not improve model fit (Churcher et al., 2013). The change in shape of the best fit relationship has implications for predicting the effect of transmission blocking interventions such as gametocytocidal drugs. The first plateau of the previous relationship (Churcher et al., 2013) predicted similar infectivity for gametocyte densities between 1 and 200 gametocytes per µl. If this was the case then an intervention that killed 99% of gametocytes would have very little effect on infectivity on a person with a density of 200 gametocytes per µl but impacted transmission considerably below this level. The new relationship presented here suggests an intervention reducing gametocyte density would have an impact on transmission to mosquitoes across the entire range of gametocyte densities observed in the field with, for example, a predicted reduction in mosquito infection prevalence of 32% to 1% when female gametocyte density is reduced from 200 to 1 female gametocytes per µl. The new work indicates that even gametocytocidal drugs with incomplete efficacy would reduce transmission.

The increased simplicity found here compared to the previously described relationship is likely to be driven by the improved accuracy of gametocyte density estimates as models fit solely to female parasites density had a similar simplified shape. The concurrent quantification of female and male gametocytes leads to an improved estimation of total gametocyte biomass and could explain why models with information on both sexes were more accurate. Similarly, combining data from microscopy and PCR could also improve overall precision when both techniques have relatively high measurement error. Though improved accuracy of gametocyte density estimates through combining imprecise measures cannot be discounted the model fit to total gametocyte density (male plus female) gave a poorer fit than the model where transmission was dependent on female density unless there were very low male parasite densities. This suggests that the number of male gametocytes may become a limiting factor for transmission at low gametocyte densities, although future studies that directly relate infectivity to mosquitoes to female and male gametocyte densities are needed to confirm this association. Such studies may benefit from an assay that targets a transcript with identical expression levels in male and female gametocytes (Meerstein-Kessel et al., 2018) or a multiplex male-female gametocyte assay that avoids uncertainties in quantifying total gametocyte biomass from two separate assays.

The work confirmed previous evidence that the proportion of male gametocytes is negatively associated with total gametocyte density (Reece et al., 2008; Robert et al., 2003; Sowunmi et al., 2008), which may reflect a strategic investment in male gametocytes to maximize the likelihood of transmission in low-density infections (fertility assurance) (Reece et al., 2008; Reece et al., 2009). The models also indicated that male gametocyte density may become a limiting factor for transmission success at low gametocyte densities. These observations are in line with in vitro findings with P. falciparum, Plasmodium berghei and Plasmodium chabaudi where infections with a higher proportion of male gametocytes gave higher transmission success at low gametocyte densities but reduced success at higher gametocyte densities (Reece et al., 2008; Mitri et al., 2009).

The presented model considerably improved the prediction of mosquito infection rates compared to our previous manuscript (Churcher et al., 2013). Nevertheless, some level of uncertainty remains, particularly between study sites with several experiments resulting in considerably lower mosquito infection rates than predicted based on gametocyte density and sex-ratio. There are several plausible reasons for this. Naturally acquired antibody responses to gametocyte antigens may reduce transmission efficiency and form a first explanation why many mosquitoes may fail to become infected when feeding on some hosts with high-density gametocyte infections. Whilst immune responses that completely prevent mosquito infections are only sporadically detected in naturally exposed populations (Stone et al., 2018), it is plausible that functional transmission reducing immunity has reduced mosquito infection rates for a proportion of gametocyte carriers in our study. Temporal fluctuations in transmission reducing immunity (Ouédraogo et al., 2011) may also have contributed to the apparent differences in infectivity between study sites that recruited gametocyte carriers at different time-points in the season. The site with the highest infectivity in the current study (Bobo Dioulasso), recruited individuals in the dry season when the impact of transmission reducing immunity may be lowest (Ouédraogo et al., 2011). The extent of between site heterogeneity in transmission should be interpreted with caution since two of the four sites had <20 study participants. At all sites malaria-infected individuals were recruited prior to malaria treatment, making it unlikely that drug-induced sterilization of circulating gametocytes may have affected our analyses. Variation in the susceptibility of the mosquito colonies to parasite genotypes may provide a second plausible reason for the imperfect model fit (Lefèvre et al., 2013). A third hypothesis could be that our quantification of gametocytes by Pfs25 and PfMGET qRT-PCR may not fully reflect gametocyte maturity and infectivity as gametocytes may be detectable in the blood stream before (Hallett et al., 2006) and after peak infectivity is reached (Ouédraogo et al., 2016). Lastly, technical issues related to RNA degradation may affect gametocyte quantification and thus yield unreliable low gametocyte density estimates (Pett et al., 2016). There were no apparent issues in maintaining the essential temperature control in the field, during transportation, or following RNA extraction for any of the samples included in this study, nor did the associations between microscopy and qRT-PCR gametocyte density estimates indicate (site-specific) RNA degradation that may have resulted in underestimations of true gametocyte densities.

The study shows that though the prevalence of mosquitoes with oocysts plateaus at high gametocyte densities the average number of oocysts in those mosquitoes continues to rise, as previously reported for P. vivax (Kiattibutr et al., 2017) and P. falciparum (Da et al., 2015). There were insufficient data to fit a model where oocyst density was dependent on female density but with a penalty for low male densities which was the best fit model for infectivity. Whether such a model would fit the oocyst density data better that the model presented here is a question for future research.

Understanding the association between gametocyte density and mosquito infection rates is of immediate relevance for malaria control efforts (Lin et al., 2016; Slater et al., 2015; Gonçalves et al., 2017). Here we show that accurate measures of female and male gametocyte density can better predict human-to-mosquito infection, and could be used to assess the infectiousness of human populations.

Materials and methods

Study populations and mosquito feeding experiments

Request a detailed protocol

Field samples were collected at four malaria endemic sites. Samples were collected prior to treatment and after written informed consent was obtained from participants or their guardian(s). Ethical clearance was provided by the National Ethics Committee of Cameroon; Ethical Review Committee of the Ministry of Health, Burkina Faso; Ethics Committee of the Malaria Research and Training Centre, Bamako; Ethics review committee Centre MURAZ; University of California, San Francisco, and London School of Hygiene and Tropical Medicine. Procedures for Ouelessebougou, Mali are described elsewhere (Dicko et al., 2016). From the trial in Ouelessebougou, baseline samples from microscopically detected gametocyte carriers were used. Additional samples were collected from asymptomatic microscopically detected gametocyte carriers aged 5–15 years in Bobo Dioulasso in Burkina Faso and Yaoundé, Cameroon. Lastly, a random selection of samples from a xenodiagnostic study in Balonghin in Burkina Faso was used (Gonçalves et al., 2017). Samples were eligible for selection if gametocytes were detected by Pfs25 QT-NASBA that has an estimated lower limit of detection between 0.02–0.1 gametocytes/µL and thus provided data-points at the lower range of gametocyte densities (Gonçalves et al., 2017). The same membrane feeding protocol was used at all sites: local Anopheles coluzzii colony mosquitoes (Mali, Cameroon and Bobo Dioulasso, Burkina Faso) or colony mosquitoes comprising a mixture of A. coluzzii, A. gambiae s.s. and hybrid forms (Balonghin, Burkina Faso) were allowed to feed for 15–20 min on heparin blood samples until dissection in 1% mercurochrome at day seven post-feeding and oocyst detection by two independent microscopists (Ouédraogo, 2013). For all sites membrane feeding and sample collection were performed prior to antimalarial treatment

Molecular analysis of samples from naturally infected gametocyte donors

Request a detailed protocol

Female gametocytes were quantified by quantitative reverse transcriptase PCR (qRT-PCR) targeting female Pfs25 mRNA, as described elsewhere in detail (Stone et al., 2017) based on established protocols (Wampfler et al., 2013). For male gametocytes we used a recently developed qRT-PCR (Stone et al., 2017) based on PfMGET (male gametocyte enriched transcript, Pf3D7_1469900), a transcript that is highly enriched in male P. falciparum gametocytes (Lasonder et al., 2016). Primer sequences are provided in Table 2. For all qRT-PCR, mRNA was extracted from blood collected in EDTA tubes by venipuncture; 100 μL of whole blood was stored at −80°C in 500 μL RNAprotect (Qiagen; for Burkina Faso and Cameroon samples) or 900 μL L6 buffer (Severn Biotech, Kidderminster, UK; for Mali samples) until automated extraction using a MagNAPure LC (Total Nucleic Acid Isolation Kit–High Performance; Roche Applied Science, Indianapolis, IN, USA). cDNA was synthesised directly from nucleic acids for the PfMGET assay, for which the primers are intron-spanning, and after DNase treatment (RQ1 DNase I Digest Kit, Promega) for the Pfs25 assay, using High Capacity cDNA Reverse Transcription Kits (Applied Biosystems, Foster City, CA). qRT-PCR results were converted to male and female gametocyte densities using standard curves (ten-fold serial dilutions from 106 to 10 gametocytes/ml) of separate male and female gametocyte populations that were generated using a transgenic parasite line expressing a male specific fluorescence marker (Lasonder et al., 2016; Stone et al., 2017). The purity of male and female trendlines was previously confirmed by staining of sorted gametocyte populations using female gametocyte specific anti-Pfg377 antibodies (Stone et al., 2017; Suárez-Cortés et al., 2016). For both Pfs25 and PfMGET qRT-PCR, a threshold for positivity was set at one gametocyte per sample (0.01/μL).

Table 2
Primer sequences for the Pfs25 female marker, and male marker PfMGET.
https://doi.org/10.7554/eLife.34463.014
Gene targetForward primerReverse primer
Pfs25GAAATCCCGTTTCATACGCTTGAGTTTTAACAGGATTGCTTGTATCTAA
PFMGETCGGTCCAAATATAAAATCCTGGTGTTTTTAATGCTGGAGCTG

Statistical analysis

Request a detailed protocol

The statistical methods used here are the same at those in the original paper (Churcher et al., 2013), which we briefly recapitulate here. qRT-PCR results are in the form of cycle-thresholds (CT, which is the number of cycles it takes for the fluorescence associated with target amplification to exceed a defined threshold. The relationship between CT and gametocyte density is estimated by fitting a linear regression to CT estimates generated using a sample with known gametocyte density (a 10-fold dilution series). Let the observed CT be denoted by y then,

(1) y=β0+β1Inx+ε

where β0 and β1 are regression coefficients estimates, x is the (known) parasite density from the dilution series and ε represents a normally distributed random error (ε ~N(0,s2)). Equation (1) can be rearranged to enable us to estimate gametocyte density from a CT measurement. We use a Bayesian hierarchical model to estimate the coefficients β0 and β1.

These gametocyte density estimates are used to determine the relationship between gametocyte density and the proportion of mosquitoes developing oocysts. Four functional forms (linear, power, hyperbolic and Gompertz [Churcher et al., 2013]) were each fit four times: on female gametocyte density alone; on male gametocyte density alone; on total gametocyte density; and finally female gametocyte density but multiplied by a function accounting for reduced transmission at low male densities. Terms allowing for different infectivity at each site were incorporated into the models. The algebraic forms of these models are given in Figure 2—source data 2. The model quantifying the uncertainty in gametocyte density estimates was fit at the same time as the regression determining the relationship between gametocyte density and infectivity using Bayesian Markov Chain Monte Carlo methods assuming a Binomial error structure for each feeding experiment. Fitting the models simultaneously enabled the uncertainty in the gametocyte density estimates to be reflected in the uncertainty of the shape of the relationship. The models were compared using the DIC with a lower value indicating the most parsimonious fit.

The relationship between gametocyte density and oocyst density was examined in an analogous way, with two exceptions: (1) A negative binomial error structure was used to describe oocyst counts and (2) The increased complexity of the model precluded the inclusion of the function accounting for reduced transmission at low male densities, so each functional form was only fit twice; on female gametocyte density and total gametocyte density.

Data availability

All raw data can be found in source data supplements of the relevant figures.

References

    1. Ouédraogo AL
    (2013)
    A protocol for membrane feeding assays to determine the infectiousness of P. falciparum naturally infected individuals to Anopheles gambiae
    MWJ 4:.

Article and author information

Author details

  1. John Bradley

    MRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, United Kingdom
    Contribution
    Conceptualization, Formal analysis, Investigation, Visualization, Writing—original draft, Writing—review and editing
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9449-4608
  2. Will Stone

    1. Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands
    2. Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, United Kingdom
    Contribution
    Conceptualization, Investigation, Methodology, Writing—original draft, Writing—review and editing
    Competing interests
    No competing interests declared
  3. Dari F Da

    Institut de Recherche en Sciences de la Santé, Direction, Bobo Dioulasso, Burkina Faso
    Contribution
    Investigation, Methodology, Writing—review and editing
    Competing interests
    No competing interests declared
  4. Isabelle Morlais

    Institut de recherche pour le développement, MIVEGEC (UM-CNRS 5290-IRD 224), Montpellier, France
    Contribution
    Investigation, Methodology, Writing—review and editing
    Competing interests
    No competing interests declared
  5. Alassane Dicko

    Malaria Research and Training Centre, Faculty of Pharmacy and Faculty of Medicine and Dentistry, University of Science, Techniques and Technologies of Bamako, Bamako, Mali
    Contribution
    Investigation, Methodology, Writing—review and editing
    Competing interests
    No competing interests declared
  6. Anna Cohuet

    Institut de recherche pour le développement, MIVEGEC (UM-CNRS 5290-IRD 224), Montpellier, France
    Contribution
    Investigation, Methodology, Writing—review and editing
    Competing interests
    No competing interests declared
  7. Wamdaogo M Guelbeogo

    Malaria Research and Training Centre, Faculty of Pharmacy and Faculty of Medicine and Dentistry, University of Science, Techniques and Technologies of Bamako, Bamako, Mali
    Contribution
    Investigation, Methodology, Writing—review and editing
    Competing interests
    No competing interests declared
  8. Almahamoudou Mahamar

    Institut de recherche pour le développement, MIVEGEC (UM-CNRS 5290-IRD 224), Montpellier, France
    Contribution
    Investigation, Methodology, Writing—review and editing
    Competing interests
    No competing interests declared
  9. Sandrine Nsango

    Faculté de Médecine et des Sciences Pharmaceutiques, Université de Douala, Douala, Cameroon
    Contribution
    Investigation, Methodology, Writing—review and editing
    Competing interests
    No competing interests declared
  10. Harouna M Soumaré

    Institut de recherche pour le développement, MIVEGEC (UM-CNRS 5290-IRD 224), Montpellier, France
    Contribution
    Investigation, Methodology
    Competing interests
    No competing interests declared
  11. Halimatou Diawara

    Institut de recherche pour le développement, MIVEGEC (UM-CNRS 5290-IRD 224), Montpellier, France
    Contribution
    Investigation, Methodology, Writing—review and editing
    Competing interests
    No competing interests declared
  12. Kjerstin Lanke

    Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands
    Contribution
    Investigation, Methodology, Writing—review and editing
    Competing interests
    No competing interests declared
  13. Wouter Graumans

    Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands
    Contribution
    Investigation, Methodology, Writing—review and editing
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3952-6491
  14. Rianne Siebelink-Stoter

    Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands
    Contribution
    Investigation, Methodology, Writing—review and editing
    Competing interests
    No competing interests declared
  15. Marga van de Vegte-Bolmer

    Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands
    Contribution
    Investigation, Methodology, Writing—review and editing
    Competing interests
    No competing interests declared
  16. Ingrid Chen

    Global Health Group, Malaria Elimination Initiative, University of California, San Francisco, San Francisco, United States
    Contribution
    Investigation, Methodology, Writing—review and editing
    Competing interests
    No competing interests declared
  17. Alfred Tiono

    Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso
    Contribution
    Investigation, Methodology, Writing—review and editing
    Competing interests
    No competing interests declared
  18. Bronner Pamplona Gonçalves

    Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, United Kingdom
    Contribution
    Resources, Investigation, Methodology, Writing—review and editing
    Competing interests
    No competing interests declared
  19. Roland Gosling

    Global Health Group, Malaria Elimination Initiative, University of California, San Francisco, San Francisco, United States
    Contribution
    Investigation, Writing—review and editing
    Competing interests
    No competing interests declared
  20. Robert W Sauerwein

    Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands
    Contribution
    Investigation, Writing—review and editing
    Competing interests
    No competing interests declared
  21. Chris Drakeley

    Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, United Kingdom
    Contribution
    Conceptualization, Supervision, Funding acquisition, Investigation, Project administration, Writing—review and editing
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4863-075X
  22. Thomas S Churcher

    MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, United Kingdom
    Contribution
    Conceptualization, Formal analysis, Investigation, Visualization, Writing—original draft
    Contributed equally with
    Teun Bousema
    For correspondence
    thomas.churcher@imperial.ac.uk
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8442-0525
  23. Teun Bousema

    1. Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands
    2. Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, United Kingdom
    Contribution
    Conceptualization, Data curation, Supervision, Funding acquisition, Investigation, Methodology, Writing—original draft, Project administration
    Contributed equally with
    Thomas S Churcher
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2666-094X

Funding

Bill and Melinda Gates Foundation (AFIRM OPP1034789 & INDIE OPP1173572)

  • Chris Drakeley
  • Teun Bousema

H2020 Excellent Science (ERC-2014-StG 639776)

  • Will Stone
  • Teun Bousema

PATH (Malaria Vaccine Iniative)

  • Dari F Da
  • Isabelle Morlais
  • Anna Cohuet
  • Teun Bousema

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Acknowledgements

This work was supported by the Bill and Melinda Gates Foundation (AFIRM OPP1034789 & INDIE OPP1173572). TB and WS are further supported by a fellowship from the European Research Council (ERC-2014-StG 639776). The PATH Malaria Vaccine Initiative funded the collection of samples in Bobo Dioulasso, Burkina Faso and Yaoundé, Cameroon.

Version history

  1. Received: December 21, 2017
  2. Accepted: May 26, 2018
  3. Accepted Manuscript published: May 31, 2018 (version 1)
  4. Version of Record published: June 21, 2018 (version 2)

Copyright

© 2018, Bradley et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,905
    Page views
  • 488
    Downloads
  • 68
    Citations

Article citation count generated by polling the highest count across the following sources: Scopus, Crossref, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. John Bradley
  2. Will Stone
  3. Dari F Da
  4. Isabelle Morlais
  5. Alassane Dicko
  6. Anna Cohuet
  7. Wamdaogo M Guelbeogo
  8. Almahamoudou Mahamar
  9. Sandrine Nsango
  10. Harouna M Soumaré
  11. Halimatou Diawara
  12. Kjerstin Lanke
  13. Wouter Graumans
  14. Rianne Siebelink-Stoter
  15. Marga van de Vegte-Bolmer
  16. Ingrid Chen
  17. Alfred Tiono
  18. Bronner Pamplona Gonçalves
  19. Roland Gosling
  20. Robert W Sauerwein
  21. Chris Drakeley
  22. Thomas S Churcher
  23. Teun Bousema
(2018)
Predicting the likelihood and intensity of mosquito infection from sex specific Plasmodium falciparum gametocyte density
eLife 7:e34463.
https://doi.org/10.7554/eLife.34463

Share this article

https://doi.org/10.7554/eLife.34463

Further reading

    1. Epidemiology and Global Health
    Zhanwei Du, Lin Wang ... Lauren A Meyers
    Short Report

    Paxlovid, a SARS-CoV-2 antiviral, not only prevents severe illness but also curtails viral shedding, lowering transmission risks from treated patients. By fitting a mathematical model of within-host Omicron viral dynamics to electronic health records data from 208 hospitalized patients in Hong Kong, we estimate that Paxlovid can inhibit over 90% of viral replication. However, its effectiveness critically depends on the timing of treatment. If treatment is initiated three days after symptoms first appear, we estimate a 17% chance of a post-treatment viral rebound and a 12% (95% CI: 0%-16%) reduction in overall infectiousness for non-rebound cases. Earlier treatment significantly elevates the risk of rebound without further reducing infectiousness, whereas starting beyond five days reduces its efficacy in curbing peak viral shedding. Among the 104 patients who received Paxlovid, 62% began treatment within an optimal three-to-five-day day window after symptoms appeared. Our findings indicate that broader global access to Paxlovid, coupled with appropriately timed treatment, can mitigate the severity and transmission of SARS-Cov-2.

    1. Epidemiology and Global Health
    Yuchen Zhang, Yitang Sun ... Kaixiong Ye
    Research Article

    Background:

    Circulating omega-3 and omega-6 polyunsaturated fatty acids (PUFAs) have been associated with various chronic diseases and mortality, but results are conflicting. Few studies examined the role of omega-6/omega-3 ratio in mortality.

    Methods:

    We investigated plasma omega-3 and omega-6 PUFAs and their ratio in relation to all-cause and cause-specific mortality in a large prospective cohort, the UK Biobank. Of 85,425 participants who had complete information on circulating PUFAs, 6461 died during follow-up, including 2794 from cancer and 1668 from cardiovascular disease (CVD). Associations were estimated by multivariable Cox proportional hazards regression with adjustment for relevant risk factors.

    Results:

    Risk for all three mortality outcomes increased as the ratio of omega-6/omega-3 PUFAs increased (all Ptrend <0.05). Comparing the highest to the lowest quintiles, individuals had 26% (95% CI, 15–38%) higher total mortality, 14% (95% CI, 0–31%) higher cancer mortality, and 31% (95% CI, 10–55%) higher CVD mortality. Moreover, omega-3 and omega-6 PUFAs in plasma were all inversely associated with all-cause, cancer, and CVD mortality, with omega-3 showing stronger effects.

    Conclusions:

    Using a population-based cohort in UK Biobank, our study revealed a strong association between the ratio of circulating omega-6/omega-3 PUFAs and the risk of all-cause, cancer, and CVD mortality.

    Funding:

    Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institute of Health under the award number R35GM143060 (KY). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.